90,217 Shares in The Cooper Companies, Inc. $COO Purchased by Commerce Bank

Commerce Bank bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 90,217 shares of the medical device company’s stock, valued at approximately $6,469,000.

Other institutional investors have also added to or reduced their stakes in the company. Avalon Trust Co bought a new position in shares of Cooper Companies during the second quarter valued at approximately $25,000. Root Financial Partners LLC raised its stake in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares in the last quarter. SJS Investment Consulting Inc. raised its stake in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares in the last quarter. Elevation Wealth Partners LLC lifted its holdings in Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after buying an additional 375 shares during the period. Finally, J.Safra Asset Management Corp purchased a new stake in Cooper Companies during the second quarter worth $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $76.22 on Monday. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The firm has a 50 day moving average of $71.93 and a 200 day moving average of $71.09. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $14.87 billion, a price-to-earnings ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on COO shares. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. Stifel Nicolaus reduced their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Robert W. Baird dropped their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Finally, Needham & Company LLC cut their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.